Trekka Therapeutics

Trekka Therapeutics is a biomaterials platform company founded in 2018 and based in Saint Paul, Minnesota. The company specializes in developing proprietary drug delivery platforms, specifically its CAPRO polymer technology and the MORE platform. These technologies are engineered to solve common formulation challenges such as poor drug solubility, stability, bioavailability, and release kinetics for small molecule drugs, biologics, and drug combinations. By offering these platforms through licensing, strategic partnerships, and joint ventures, Trekka aims to help pharmaceutical and biotech companies improve the efficacy and safety of their therapeutic candidates.

The company's approach provides partners with specialized excipients and development services that span from initial drug identification and engineering to pilot testing and GMP-ready manufacturing processes. By addressing delivery limitations, Trekka helps its collaborators advance drug programs across various medical disciplines, including oncology, ophthalmology, and neurology. Trekka operates as a platform-focused organization rather than a single-asset developer, utilizing its technology to repurpose existing APIs and optimize new therapeutic formulations to meet unmet clinical needs.